Skip to main content

Appropriate role for sentinel node biopsy after neoadjuvant chemotherapy in patients with early-stage breast cancer.

Publication ,  Journal Article
Lyman, GH
Published in: J Clin Oncol
January 20, 2015

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

January 20, 2015

Volume

33

Issue

3

Start / End Page

232 / 234

Location

United States

Related Subject Headings

  • Sentinel Lymph Node Biopsy
  • Oncology & Carcinogenesis
  • Neoadjuvant Therapy
  • Lymph Nodes
  • Humans
  • Female
  • Breast Neoplasms
  • Antineoplastic Combined Chemotherapy Protocols
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H. (2015). Appropriate role for sentinel node biopsy after neoadjuvant chemotherapy in patients with early-stage breast cancer. J Clin Oncol, 33(3), 232–234. https://doi.org/10.1200/JCO.2014.58.9838
Lyman, Gary H. “Appropriate role for sentinel node biopsy after neoadjuvant chemotherapy in patients with early-stage breast cancer.J Clin Oncol 33, no. 3 (January 20, 2015): 232–34. https://doi.org/10.1200/JCO.2014.58.9838.
Lyman, Gary H. “Appropriate role for sentinel node biopsy after neoadjuvant chemotherapy in patients with early-stage breast cancer.J Clin Oncol, vol. 33, no. 3, Jan. 2015, pp. 232–34. Pubmed, doi:10.1200/JCO.2014.58.9838.

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

January 20, 2015

Volume

33

Issue

3

Start / End Page

232 / 234

Location

United States

Related Subject Headings

  • Sentinel Lymph Node Biopsy
  • Oncology & Carcinogenesis
  • Neoadjuvant Therapy
  • Lymph Nodes
  • Humans
  • Female
  • Breast Neoplasms
  • Antineoplastic Combined Chemotherapy Protocols
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis